Man working with petri dish.

Demonstrating drug potency early in cell therapy development: Why it’s challenging and why it matters

A shift in FDA focus: Clinical to CMC

Why demonstrating potency is a challenge for advanced therapies

Best practices for potency measurement

Sign up and receive notifications when we post new content

*
*
Yes, I would like to learn more about Cardinal Health’s products and services by email. I can withdraw my consent or change my preferences by visiting Update Preferences. Visit Privacy Policy for more information about Cardinal Health’s privacy practices.